Press Releases China SXT Pharmaceuticals, Inc.

Equities

SXTC

VGG2161P1403

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-21 EDT			5-day change	1st Jan Change
1.14 ^USD	-5.79%		+2.70%	-71.28%

04-05	China SXT Pharmaceuticals, Inc. Reports Earnings Results for the Half Year Ended September 30, 2023	CI
02-08	Wall Street Set to Open Flat Wednesday; Jobless Claims Fall More Than Expected	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

China SXT Pharmaceuticals : May 2024 Note - Form 6-K	05-14	PU
China SXT Pharmaceuticals : MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS - Form 6-K	04-05	PU
China SXT Pharmaceuticals, Inc. Regained Compliance with Nasdaq’s Minimum Bid Price Rule	23-10-26	AQ
China SXT Pharmaceuticals Announces One-for-Twenty-five Reverse Stock Split	23-10-04	AQ
China SXT Pharmaceuticals, Inc. Receives 180-day Extension from Nasdaq to Meet Minimum Bid Price Rule	23-05-10	AQ
China SXT Pharmaceuticals : Purchase Agreement - Form 6-K	23-03-23	PU
China SXT Pharmaceuticals : Securities Purchase Agreement - Form 6-K	23-02-28	PU
China SXT Pharmaceuticals : MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS - Form 6-K	23-02-24	PU
China SXT Pharmaceuticals : Securities Purchase Agreement - Form 6-K	22-12-23	PU
China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiency	22-11-07	AQ
China SXT Pharmaceuticals : Securities Purchase Agreement - Form 6-K	22-10-12	PU
China SXT Pharmaceuticals, Inc. Announces 1 for 20 Reverse Share Split	22-05-18	GL
China SXT Pharmaceuticals, Inc. Announces 1 for 20 Reverse Share Split	22-05-18	AQ
China SXT Pharmaceuticals, Inc. Enters into Securities Purchase Agreement to Issue a 6% Convertible Promissory Note in the Original Principal Amount of $2.8 Million	22-03-14	GL
China SXT Pharmaceuticals, Inc. Enters into Securities Purchase Agreement to Issue a 6% Convertible Promissory Note in the Original Principal Amount of $2.8 Million	22-03-14	GL
China SXT Pharmaceuticals : Announces Proposed Underwritten Public Offering of Ordinary Shares and Pre-Funded Warrants to Purchase Ordinary Shares - Form 6-K	22-01-21	PU
China SXT Pharmaceuticals, Inc. Announces Successful Closing of $4.1 Million Follow-on Underwritten Offering of Ordinary Shares and Pre-Funded Warrants With Simultaneous Exercise of the Over-Allotment	22-01-20	AQ
China SXT Pharmaceuticals, Inc. Prices $3.5 Million Underwritten Public Offering of Ordinary Shares and Pre-Funded Warrants to Purchase Ordinary Shares	22-01-18	GL
China SXT Pharmaceuticals, Inc. Prices $3.5 Million Underwritten Public Offering of Ordinary Shares and Pre-Funded Warrants to Purchase Ordinary Shares	22-01-18	GL
China SXT Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Ordinary Shares and Pre-Funded Warrants to Purchase Ordinary Shares	22-01-14	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases China SXT Pharmaceuticals, Inc.

Equities

SXTC

VGG2161P1403

Press Releases

Filters